Neurology Alert
RSSArticles
-
Clopridogrel and Aspirin in Symptomatic Carotid Stenosis: The CARESS Trial
Clopidogrel and aspirin therapy is more effective than aspirin alone in reducing asymptotic MES in patients with recently symptomatic CS. -
Treating Intracerebral Hemorrhage: Where Does the Blade Fade Away and the Neuro-Intensivist Move In?
Surgical treatment was associated with a cost savings due to shorter hospital stays and the use of fewer services upon discharge into the community. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: Is Nesiritide Associated with a Higher Death Rate?
Nesiritide, Scios' intravenous recombinant form of human B-type naturetic peptide, has been widely used for the treatment of congestive heart failure in hospitalized patients. -
Whipple’s Disease
Progression of the cord lesion and lack of steroid response prompted antibiotic treatment for Whipple’s disease. -
Statins for the Treatment of Alzheimer’s Disease
Atorvastatin reduces cholesterol levels and improves cognition in Alzheimer’s disease patients. -
Magnesium Sulfate is a Promising Neuroprotective Agent
The use of magnesium may reduce ischemic complications after SAH and thereby may reduce the risk of poor outcome after SAH, but as yet, the evidence for its use in clinical practice is inconclusive. -
Pharmacology Watch: The FDA Pulls Another COX-2 Inhibitor Off the Market
The FDA has asked Pfizer to withdraw valdecoxib (Bextra) from the market due to safety concerns. -
Clinical Briefs in Primary Care Supplement
-
Pregnancy and the Myasthenic
In 15%, and without correlation to maternal disease severity or antibody level, neonatal MG due to the transplacental transfer of maternal antibodies results in transient weakness of the newborn that resolves within 12 weeks.